Suchergebnisse - "145155-23-3"

PubPharm (142)

1

Comparing the outcomes of treatment with INF-β 1-a (interferon beta-1a) and IFN-β 1-b (interferon beta-1b) among COVID-19 inpatients

enthalten in: International immunopharmacology | 2021

von Seyfi, S. | Latifi, K. | Amri Male, P. | +3

2

Combination of (interferon beta-1b, lopinavir/ritonavir and ribavirin) versus favipiravir in hospitalized patients with non-critical COVID-19 : A cohort study

enthalten in: PloS one | 2021

von A Malhani, A. | A Enani, M. | Saheb Sharif-Askari, F. | +5

3

Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in China

enthalten in: Clinical drug investigation | 2019

von Xu, Y. | Mao, N. | Chirikov, V. | +5

4

Depression, anxiety and stress severities in multiple sclerosis patients using injectable versus oral treatments

enthalten in: Journal of comparative effectiveness research | 2017

von Al-Hussain, F. | Al-Salloum, N. | Alazwary, N. | +3

5

Immunogenicity of Recombinant Human Interferon Beta-1b in Immune-Tolerant Transgenic Mice Corresponds with the Biophysical Characteristics of Aggregates

enthalten in: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research | 2016

von Abdolvahab, M. | Fazeli, A. | Halim, A. | +3

6

A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosis

enthalten in: Human molecular genetics | 2015

von Harari, D. | Orr, I. | Rotkopf, R. | +2

7

Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis : a systematic review and mixed treatment comparison

enthalten in: Current medical research and opinion | 2014

von Hutchinson, M. | Fox, R. | Havrdova, E. | +6

CommentIn: Curr Med Res Opin. 2015 Jan;31(1):51-2. - PMID 25265130

8

Comparison of site-specific PEGylations of the N-terminus of interferon beta-1b : selectivity, efficiency, and in vivo/vitro activity

enthalten in: Bioconjugate chemistry | 2014

von Zhou, Z. | Zhang, J. | Sun, L. | +2

9

Pharmacoeconomic analysis of the efficacy of natalizumab in relapsing-remitting multiple sclerosis

enthalten in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova | 2014

von Sabanov, A. | Luneva, A. | Matveev, N.

10

Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis

enthalten in: The pharmacogenomics journal | 2013

von Croze, E. | Yamaguchi, K. | Knappertz, V. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]